Categories: FitnessNews

Publix Fort Lauderdale A1A Marathon & Half Marathon Returns on the weekend of February 13-15th

FORT LAUDERDALE, Fla., Jan. 20, 2026 /PRNewswire/ — The Publix Fort Lauderdale A1A Marathon & Half Marathon Presented by Colavita returns for its 21st annual running on Sunday, February 15th, continuing its legacy as one of South Florida’s premier running events. The race draws thousands of runners to Fort Lauderdale each year and highlights the city’s strong focus on health, wellness, and active living.

Known for its flat, fast, scenic oceanfront course along A1A, the event offers multiple race options designed for runners of all levels. Participants can choose from a full marathon, half marathon, Fresh from Florida 6K, Celsius Fort Lauderdale 5K, or A1A Kid’s Fun Run, making it a true weekend of movement and motivation for the entire community. This marathon is also a Boston Marathon-qualifying race.

“Year after year, this event brings incredible energy to the city,” said event organizers. “It’s inspiring to see thousands of people come together with a shared goal of pushing themselves, supporting one another, and embracing a healthy lifestyle—all while enjoying a beautiful beachfront course.”

The marathon generates significant local impact, bringing visitors to area hotels, restaurants, and businesses while fostering community engagement around fitness and well-being.

The Publix Fort Lauderdale A1A Marathon weekend includes a race expo, community activations, and post-race celebrations, creating a full experience for runners and spectators alike.

More information and registration details are available at PublixA1AMarathon.com.

View original content:https://www.prnewswire.com/news-releases/publix-fort-lauderdale-a1a-marathon–half-marathon-returns-on-the-weekend-of-february-13-15th-302662795.html

SOURCE Exclusive Sports Marketing, Inc.

Staff

Recent Posts

University Medical Center Southern Nevada Becomes First Hospital in Nevada to Earn Magnet Recognition

Prestigious designation recognizes excellence in nursing, patient care, and clinical outcomesLAS VEGAS, Jan. 24, 2026…

3 hours ago

Direct Meds NAD+ Injections Consumer Report 2026: Comparing Supplement and Peptide Alternatives, Dosage, Benefits & Side Effects

A consumer-focused examination of NAD+ injections, NAD+ supplements, NAD+ peptides, NAD+ dosage protocols, documented NAD+…

3 hours ago

Immunovant to Report Financial Results for the Third Quarter Ended December 31, 2025, and Provide Business Update on Friday, February 6, 2026

DURHAM, N.C. and NEW YORK, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Immunovant (Nasdaq: IMVT) today…

3 hours ago

Nexalin Technology Receives Nasdaq Listing Status Notification

HOUSTON, TX, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL) (the “Company”…

3 hours ago

MEDIROM Forms New Special Mission Team to Drive World ID Adoption Across 3,000 Locations Through Partnership with Tools for Humanity

TOKYO, Jan. 23, 2026 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Headquarters: Minato-ku, Tokyo; President…

3 hours ago